← Back to Clinical Trials
Recruiting NCT05899933

Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Peri-Implantitis
Sponsor National and Kapodistrian University of Athens
Study Type INTERVENTIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2023-07-28
Completion 2026-12
Interventions
Non-surgical peri-implant therapyImplantoplastyErythritol Air-abrasive device

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the present study is to compare the 1-year clinical, radiographic and microbiological outcomes and patients' satisfaction following surgical treatment of peri-implantitis after applying two different surface modification methods. Secondarily, analysis and comparison of the microbiological results of implants diagnosed and treated for peri-implantitis with healthy implants will be performed.

Eligibility Criteria

Inclusion Criteria: General Inclusion Criteria: * Participants ≥ 18 years and ≤ 80 years of age * Non-smokers based on the patients' self-reported smoking status, defined as patients who had never smoked or had quit smoking at least 2 years ago * Implants in function for more than 1 year after suprastructure connection Inclusion Criteria for implants diagnosed with Peri-Implantitis: * Presence of at least one implant diagnosed with peri-implantitis defined as presence of bleeding on probing and/or suppuration, probing pocket depth ≥6 mm and ≥3 mm of detectable bone loss after initial re-modelling * Absence of implant mobility * in participants with more than one implant, the implant with the worst clinical condition will be studied. Inclusion Criteria for implants diagnosed with Peri-Implant Health: * Absence of peri-implant signs of inflammation (redness, swelling) * Lack of bleeding on probing * Absence of bone loss beyond crestal bone level changes resulting from initial remodeling,

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}